BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7735919)

  • 1. A diagnostic assay for the Wiskott-Aldrich syndrome and its variant forms.
    Siminovitch KA; Greer WL; Novogrodsky A; Axelsson B; Somani AK; Peacocke M
    J Investig Med; 1995 Apr; 43(2):159-69. PubMed ID: 7735919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of human peripheral blood lymphocytes by periodate, galactose oxidase, soybean agglutinin, and peanut agglutinin: differential effects of adherent cells.
    Novogrodsky A; Stenzel KH; Rubin AL
    J Immunol; 1977 Mar; 118(3):852-7. PubMed ID: 191527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of responding cells in oxidative mitogen stimulation. I. Ia+ cells and Ly-1+2+ cells are required for the proliferative response.
    Phillips ML; Wettstein PJ; O'Brien RL; Parker JW; Frelinger JA
    J Immunol; 1980 Jun; 124(6):2693-9. PubMed ID: 6246169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of chemotactic lymphokine synthesis and mononuclear leukocyte chemotaxis in Wiskott-Aldrich syndrome.
    Altman LC; Snyderman R; Blaese RM
    J Clin Invest; 1974 Aug; 54(2):486-93. PubMed ID: 4136226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses.
    Molina IJ; Sancho J; Terhorst C; Rosen FS; Remold-O'Donnell E
    J Immunol; 1993 Oct; 151(8):4383-90. PubMed ID: 8409409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extent of oxidative mitogenesis does not correlate with the degree of aldehyde formation of the T lymphocyte membrane.
    Roffman E; Wilchek M
    J Immunol; 1986 Jul; 137(1):40-4. PubMed ID: 3086457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective impairment of CD43-mediated T cell activation in the Wiskott-Aldrich syndrome.
    Siminovitch KA; Greer WL; Axelsson B; Rubin LA; Novogrodsky A; Peacocke M
    Immunodeficiency; 1993; 4(1-4):99-108. PubMed ID: 8167744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface glycoproteins of rat lymphocytes. I. Correlation of mitogenic stimulation by periodate or neuraminidase and galactose oxidase with the presence of papain-sensitive glycoproteins.
    Mitchell RN; Bowers WE
    J Immunol; 1978 Dec; 121(6):2181-92. PubMed ID: 214497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome.
    Zabay JM; Fontán G; Campos A; García-Rodriguez MC; Pascual-Salcedo D; Bootello A; de la Concha EG
    Clin Exp Immunol; 1984 Apr; 56(1):23-8. PubMed ID: 6609033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative pathway induction of T lymphocyte mitogen stimulation.
    Peters JH; Schimmelpfeng L
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):169-82. PubMed ID: 218373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and growth factor requirements for activation of human T lymphocytes by neuraminidase and galactose oxidase-treated lymphoid cells.
    Lipkowitz S; Rubin AL; Stenzel KH; Novogrodsky A
    J Immunol; 1983 Jun; 130(6):2702-7. PubMed ID: 6602177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of chronic lymphatic leukaemia cells by pokeweed mitogen after treatment with neuraminidase-galactose oxidase.
    Zafar MN; Pittman S; Cherchi M; Catovsky D
    Clin Exp Immunol; 1981 Apr; 44(1):124-8. PubMed ID: 6973427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogenic properties of neuraminidase and galactose oxidase-treated lymphoblastoid cells and plasma membranes for peripheral blood lymphocytes.
    Arnold A; Rubin AL; Novogrodsky A; Stenzel KH
    J Immunol; 1984 Nov; 133(5):2569-76. PubMed ID: 6332856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human lymphocyte subpopulations: giant SRBC rosettes.
    Yu DT
    J Immunol; 1976 Jun; 116(6):1719-24. PubMed ID: 178802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early mitogen-induced metabolic events essential to proliferation of human T lymphocytes: dependence of specific events on the influence of adherent accessory cells.
    Bruszewski WB; Bruszewski JA; Tonnu H; Ferezy SL; O'Brien RL; Parker JW
    J Immunol; 1984 Jun; 132(6):2837-43. PubMed ID: 6609961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of neuraminidase and galactose oxidase on murine lymphocytes. I. Evidence for the differential delivery of signal(s) leading to cell proliferation and the differentiation of cytotoxic T cells.
    Kuppers RC; Henney CS
    J Immunol; 1977 Dec; 119(6):2163-71. PubMed ID: 303259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of suppressor cells after activation of human peripheral blood mononuclear cells with sodium periodate.
    Lomnitzer R; Rabson AR
    Immunology; 1982 Jan; 45(1):7-13. PubMed ID: 6276296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The usefulness of X-linked polymorphic loci as gene markers to track X allele and chimerism in a post-allogeneic peripheral blood stem cell transplant patient with Wiskott-Aldrich syndrome.
    Sasanakul W; Hongeng S; Chuansumrit A; Chaiyaratana W; Pakakasama S; Hathirat P
    J Med Assoc Thai; 2001 Mar; 84(3):379-84. PubMed ID: 11460939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of human lymphocyte mediators after activation with periodate or neuraminidase and galactose oxidase.
    Greineder DK; Rocklin RE; David JR
    J Immunol; 1979 Dec; 123(6):2804-7. PubMed ID: 227960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.